We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Mission Bio, the pioneer in high-throughput single-cell DNA and multi-omics analysis, has signed an agreement with Alliance Global (AGBL Group), distributors of biomedical technology and products.
Single-cell genomics developer Mission Bio has made three new hires to build out its executive team, following a $30 million series B round late last year and a new deal to provide sequencing services to LabCorp and its Covance drug development business.
Since launching at the end of 2017 with a focus on blood cancers, Mission Bio has built out its single-cell genomics platform to include custom offerings....